Trial Outcomes & Findings for GEBT Telehealth Administration Usability Study (NCT NCT04684992)

NCT ID: NCT04684992

Last Updated: 2021-08-24

Results Overview

Ability to prepare GEBT will be assessed by the telehealth administrator's observation of the patient.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

36 participants

Primary outcome timeframe

1 day

Results posted on

2021-08-24

Participant Flow

Participant milestones

Participant milestones
Measure
GEBT Telehealth Administration Usability
Establish the usability of a telehealth platform for the administration of GEBT GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT
Overall Study
STARTED
36
Overall Study
COMPLETED
34
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
GEBT Telehealth Administration Usability
n=34 Participants
Establish the usability of a telehealth platform for the administration of GEBT GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT
Age, Categorical
<=18 years
0 Participants
n=34 Participants
Age, Categorical
Between 18 and 65 years
31 Participants
n=34 Participants
Age, Categorical
>=65 years
3 Participants
n=34 Participants
Sex: Female, Male
Female
22 Participants
n=34 Participants
Sex: Female, Male
Male
12 Participants
n=34 Participants

PRIMARY outcome

Timeframe: 1 day

Ability to prepare GEBT will be assessed by the telehealth administrator's observation of the patient.

Outcome measures

Outcome measures
Measure
GEBT Telehealth Administration Usability
n=34 Participants
Establish the usability of a telehealth platform for the administration of GEBT GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT
Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions
Transfer meal to cooking cup without spilling
34 participants
Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions
Remove oxygen absorber
34 participants
Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions
Added correct amount of water
34 participants
Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions
Egg meal cooked for correct length of time
34 participants
Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions
Egg flipped middle of cooking
34 participants
Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions
Egg appeared adequately cooked
34 participants

PRIMARY outcome

Timeframe: up to 1 week

Population: Study participants assessed on a patient questionnaire whether the meal preparation instructions were clear and easy to follow.

Ability to prepare GEBT will be assessed by a patient questionnaire.

Outcome measures

Outcome measures
Measure
GEBT Telehealth Administration Usability
n=34 Participants
Establish the usability of a telehealth platform for the administration of GEBT GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT
Patient Ability to Prepare and Administer the 13C-Spirulina GEBT, Under the Supervision of a Telehealth Professional, According to Instructions
34 participants

PRIMARY outcome

Timeframe: 2-4 days

Ability to complete the GEBT test request form will be assessed by Cairn accessioning personnel upon receipt of returned breath samples.

Outcome measures

Outcome measures
Measure
GEBT Telehealth Administration Usability
n=34 Participants
Establish the usability of a telehealth platform for the administration of GEBT GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT
Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions
Test Request Form returned with samples
34 participants
Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions
Patient Information Entered Correctly
33 participants
Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions
Pre-meal sample times recorded
33 participants
Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions
Meal start/end times recorded correctly
34 participants
Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions
Post-meal sample times recorded
34 participants

PRIMARY outcome

Timeframe: up to 1 week

Population: Participants assessed easy of completing the GEBT test request form.

Ability to complete the GEBT test request form will be assessed by a patient questionnaire.

Outcome measures

Outcome measures
Measure
GEBT Telehealth Administration Usability
n=34 Participants
Establish the usability of a telehealth platform for the administration of GEBT GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT
Patient Ability to Complete the GEBT Test Request Form, Under the Supervision of a Telehealth Professional, According to the Instructions
34 participants

PRIMARY outcome

Timeframe: up to 1 week

Ability to collect GEBT breath samples will be assessed by examination of GEBT results for participants (ensuring adequate CO2 in each sample/delta values follow expected pattern if collected in correct order).

Outcome measures

Outcome measures
Measure
GEBT Telehealth Administration Usability
n=34 Participants
Establish the usability of a telehealth platform for the administration of GEBT GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT
Patient Ability to Collect GEBT Breath Samples Under the Supervision of a Telehealth Professional
Telehealth administrator observed condensate
33 participants
Patient Ability to Collect GEBT Breath Samples Under the Supervision of a Telehealth Professional
Post meal samples collected within 5 minutes
33 participants
Patient Ability to Collect GEBT Breath Samples Under the Supervision of a Telehealth Professional
Clinical lab personnel observed condensate
34 participants
Patient Ability to Collect GEBT Breath Samples Under the Supervision of a Telehealth Professional
Adequate %CO2 (>1%)
34 participants
Patient Ability to Collect GEBT Breath Samples Under the Supervision of a Telehealth Professional
Samples follow excretion curve shape
34 participants
Patient Ability to Collect GEBT Breath Samples Under the Supervision of a Telehealth Professional
Breath samples easy to collect
34 participants

PRIMARY outcome

Timeframe: Up to 3 weeks

Ability to ship GEBT kits/breath samples to/from home will be assessed by surveying patients regarding shipping and by recording the dates that kits were shipped and received

Outcome measures

Outcome measures
Measure
GEBT Telehealth Administration Usability
n=34 Participants
Establish the usability of a telehealth platform for the administration of GEBT GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT
Ability to Successfully Ship Kits/Breath Samples to/From Home
Kit arrived before test administration
34 participants
Ability to Successfully Ship Kits/Breath Samples to/From Home
Breath samples received within 28-days
34 participants

PRIMARY outcome

Timeframe: 1 day

Verification that the software is user friendly and not subject to frequent failures during use will be assessed by a telehealth administrator questionnaire

Outcome measures

Outcome measures
Measure
GEBT Telehealth Administration Usability
n=34 Participants
Establish the usability of a telehealth platform for the administration of GEBT GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT
Ability of a Telehealth Platform to Function Correctly
No platform issues?
32 participants
Ability of a Telehealth Platform to Function Correctly
No lost connection?
32 participants
Ability of a Telehealth Platform to Function Correctly
No text reminder issues?
31 participants

PRIMARY outcome

Timeframe: Up to 3 weeks

Population: Participants assessed reliability and ease of use of telehealth platform.

Verification that the software is user friendly and not subject to frequent failures during use will be assessed by a patient questionnaire

Outcome measures

Outcome measures
Measure
GEBT Telehealth Administration Usability
n=34 Participants
Establish the usability of a telehealth platform for the administration of GEBT GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT
Ability of a Telehealth Platform to Function Correctly
32 participants

PRIMARY outcome

Timeframe: Up to 3 weeks

Population: There were no adverse events associated with telehealth administration via the telehealth procedure (e.g., burns during microwave cooking or injuries from breath collection apparatus).

Any adverse events reported will be reviewed by Cairn's medical director to assess that there is no more than expected frequency of adverse events during administration of GEBT by a telehealth professional than would be expected during administration of GEBT in a clinician's facility. This will be performed by comparing the current rate of events in a physician's office versus under the supervision of a telehealth professional as identified through the risk analyses performed for GEBT administration.

Outcome measures

Outcome measures
Measure
GEBT Telehealth Administration Usability
n=34 Participants
Establish the usability of a telehealth platform for the administration of GEBT GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT
Safety of Telehealth Administration of 13C-Spirulina GEBT Versus Administration in a Clinician's Facility
0 AEs associated with telehealth

Adverse Events

GEBT Telehealth Administration Usability

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
GEBT Telehealth Administration Usability
n=34 participants at risk
Establish the usability of a telehealth platform for the administration of GEBT GEBT Telehealth Administration Usability: Establish the usability of a telehealth platform for the administration of GEBT
Gastrointestinal disorders
Excessive burping and nausea
2.9%
1/34 • 3 months
Gastrointestinal disorders
Severe bloating and excessive gas
2.9%
1/34 • 3 months
Gastrointestinal disorders
Vomiting and dehydration
2.9%
1/34 • 3 months

Additional Information

Chief Scientist and Compliance Officer

Cairn Diagnostics

Phone: 615-376-5464

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place